The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a 12-month service contract for the maintenance of Illumina NextSeq 2000 and 1000 sequencing instruments. The contract will cover comprehensive service requirements, including full coverage for parts, labor, and travel, preventative maintenance, remote technical support, and on-site applications support, with specific performance periods outlined for each instrument. This procurement is critical for the Vaccine Immunology Program (VIP) to ensure the operational efficiency of essential sequencing equipment used in research. Interested vendors must submit a capability statement, including on-site response time and manufacturer certification, by 10:00 am EST on March 21, 2025, via the NIAID electronic Simplified Acquisition Submission System (eSASS). For further inquiries, vendors can contact Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.